oncolytic การใช้

• The product Reolysin harnesses the oncolytic capabilities of naturally occurring Ras pathway.
• It was the first approval of an oncolytic virus in the West.
• :: See Coley's toxins and Oncolytic virus.
• Oncolytic viruses are viruses that preferably infect cancer cells.
• A further approach involves the use of immunotherapy, such as oncolytic viruses.
• In 2005 Chinese company, Shanghai Sunway Biotech registered an oncolytic adenovirus, a immunotherapy.
• T-Vec is a genetically engineered herpes virus ( an oncolytic herpes virus ).
• ColoAd1 from PsiOxus Therapeutics has entered Phase I / II clinical study with its oncolytic vaccine.
• In the 1940s-50s some of the earliest human clinical trials with oncolytic viruses were started.
• For example, oncolytic vaccines based on the Ad5 serotype have relatively poor clinical efficacy as monotherapies.
• The initial discovery of the virus'oncolytic properties were limited to only a few types of cancer.
• Pexa-Vec is an engineered oncolytic virus that selectively destroys cancer cells and induces tumor immune response.
• Novel oncolytic viruses in Jennerex pipeline are engineered through the Selective Oncolytic Vaccinia Engineering ( SOLVE ) platform.
• Novel oncolytic viruses in Jennerex pipeline are engineered through the Selective Oncolytic Vaccinia Engineering ( SOLVE ) platform.
• Indeed, they are commonly oncolytic, showing a strong tendency to replicate preferentially in cells with transformed phenotypes.
• In 1996, the first approval was given in Europe for a clinical trial using the oncolytic virus HSV1716.
• The main focus of Genelux is oncolytic immunotherapy based on attenuated, genetically engineered oncolytic viruses as therapeutic agent.
• The main focus of Genelux is oncolytic immunotherapy based on attenuated, genetically engineered oncolytic viruses as therapeutic agent.
• His published work on oncolytic adenoviruses includes Onyx-015 and has appeared in " Nature ".
• Another approach is to generate an immune response " in situ " in the patient using oncolytic viruses.